BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

News: BNO Bionomics Ltd Updates On Phase 2 Post Traumatic Stress Disorder Trial Results

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    02/10/18
    10:20
    Post #: 35962787

    Oct 2 (Reuters) - Bionomics Ltd (BNO) :

    • UPDATES ON PHASE 2 POST TRAUMATIC STRESS DISORDER TRIAL RESULTS
    • TRIAL DID NOT MEET PRIMARY ENDPOINT OF DECREASE IN PTSD SYMPTOMS AS MEASURED BY CAPS-5 AT 12 WEEKS
    • BNC210 TREATMENT WAS SAFE AND WELL TOLERATED

    Source text (http//reut.rs/2OqJRF6)

    (([email protected];))

    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
LM1 High-grade targets in focus as drilling begins at Evanston
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner
right-arrow Created with Sketch.
AII Why Almonty Industries is THE tungsten mining stock to watch
right-arrow Created with Sketch.
NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.